Global Fluoxetine Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Fluoxetine

• 1.1 Definition of Fluoxetine
• 1.2 Fluoxetine Segment by Type
  • 1.2.1 Global Fluoxetine Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Tablets
  • 1.2.3 Capsules
  • 1.2.4 Oral Solution
• 1.3 Fluoxetine Segment by Applications
  • 1.3.1 Global Fluoxetine Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Depression
  • 1.3.3 Obsessive–compulsive disorder
  • 1.3.4 Panic disorder
  • 1.3.5 Bulimia nervosa
  • 1.3.6 Others
• 1.4 Global Fluoxetine Overall Market
  • 1.4.1 Global Fluoxetine Revenue (2014-2025)
  • 1.4.2 Global Fluoxetine Production (2014-2025)
  • 1.4.3 North America Fluoxetine Status and Prospect (2014-2025)
  • 1.4.4 Europe Fluoxetine Status and Prospect (2014-2025)
  • 1.4.5 China Fluoxetine Status and Prospect (2014-2025)
  • 1.4.6 Japan Fluoxetine Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Fluoxetine Status and Prospect (2014-2025)
  • 1.4.8 India Fluoxetine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Fluoxetine
• 2.3 Manufacturing Process Analysis of Fluoxetine
• 2.4 Industry Chain Structure of Fluoxetine

3 Development and Manufacturing Plants Analysis of Fluoxetine

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Fluoxetine Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Fluoxetine
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Fluoxetine Production and Capacity Analysis
• 4.2 Fluoxetine Revenue Analysis
• 4.3 Fluoxetine Price Analysis
• 4.4 Market Concentration Degree

5 Fluoxetine Regional Market Analysis

• 5.1 Fluoxetine Production by Regions
  • 5.1.1 Global Fluoxetine Production by Regions
  • 5.1.2 Global Fluoxetine Revenue by Regions
• 5.2 Fluoxetine Consumption by Regions
• 5.3 North America Fluoxetine Market Analysis
  • 5.3.1 North America Fluoxetine Production
  • 5.3.2 North America Fluoxetine Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Fluoxetine Import and Export
• 5.4 Europe Fluoxetine Market Analysis
  • 5.4.1 Europe Fluoxetine Production
  • 5.4.2 Europe Fluoxetine Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Fluoxetine Import and Export
• 5.5 China Fluoxetine Market Analysis
  • 5.5.1 China Fluoxetine Production
  • 5.5.2 China Fluoxetine Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Fluoxetine Import and Export
• 5.6 Japan Fluoxetine Market Analysis
  • 5.6.1 Japan Fluoxetine Production
  • 5.6.2 Japan Fluoxetine Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Fluoxetine Import and Export
• 5.7 Southeast Asia Fluoxetine Market Analysis
  • 5.7.1 Southeast Asia Fluoxetine Production
  • 5.7.2 Southeast Asia Fluoxetine Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Fluoxetine Import and Export
• 5.8 India Fluoxetine Market Analysis
  • 5.8.1 India Fluoxetine Production
  • 5.8.2 India Fluoxetine Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Fluoxetine Import and Export

6 Fluoxetine Segment Market Analysis (by Type)

• 6.1 Global Fluoxetine Production by Type
• 6.2 Global Fluoxetine Revenue by Type
• 6.3 Fluoxetine Price by Type

7 Fluoxetine Segment Market Analysis (by Application)

• 7.1 Global Fluoxetine Consumption by Application
• 7.2 Global Fluoxetine Consumption Market Share by Application (2014-2019)

8 Fluoxetine Major Manufacturers Analysis

• 8.1 Teva
  • 8.1.1 Teva Fluoxetine Production Sites and Area Served
  • 8.1.2 Teva Product Introduction, Application and Specification
  • 8.1.3 Teva Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Sun Pharmaceutical
  • 8.2.1 Sun Pharmaceutical Fluoxetine Production Sites and Area Served
  • 8.2.2 Sun Pharmaceutical Product Introduction, Application and Specification
  • 8.2.3 Sun Pharmaceutical Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Sandoz
  • 8.3.1 Sandoz Fluoxetine Production Sites and Area Served
  • 8.3.2 Sandoz Product Introduction, Application and Specification
  • 8.3.3 Sandoz Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Mylan
  • 8.4.1 Mylan Fluoxetine Production Sites and Area Served
  • 8.4.2 Mylan Product Introduction, Application and Specification
  • 8.4.3 Mylan Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Wockhardt
  • 8.5.1 Wockhardt Fluoxetine Production Sites and Area Served
  • 8.5.2 Wockhardt Product Introduction, Application and Specification
  • 8.5.3 Wockhardt Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Dr.Reddy's Laboratories
  • 8.6.1 Dr.Reddy's Laboratories Fluoxetine Production Sites and Area Served
  • 8.6.2 Dr.Reddy's Laboratories Product Introduction, Application and Specification
  • 8.6.3 Dr.Reddy's Laboratories Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Pharmaceutical Associates Inc.
  • 8.7.1 Pharmaceutical Associates Inc. Fluoxetine Production Sites and Area Served
  • 8.7.2 Pharmaceutical Associates Inc. Product Introduction, Application and Specification
  • 8.7.3 Pharmaceutical Associates Inc. Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Lannett Company
  • 8.8.1 Lannett Company Fluoxetine Production Sites and Area Served
  • 8.8.2 Lannett Company Product Introduction, Application and Specification
  • 8.8.3 Lannett Company Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Aurobindo Pharma
  • 8.9.1 Aurobindo Pharma Fluoxetine Production Sites and Area Served
  • 8.9.2 Aurobindo Pharma Product Introduction, Application and Specification
  • 8.9.3 Aurobindo Pharma Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Alembic Pharmaceuticals
  • 8.10.1 Alembic Pharmaceuticals Fluoxetine Production Sites and Area Served
  • 8.10.2 Alembic Pharmaceuticals Product Introduction, Application and Specification
  • 8.10.3 Alembic Pharmaceuticals Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Alvogen
• 8.12 Torrent Pharmaceuticals
• 8.13 Suzhou YUSHI Pharmaceutical
• 8.14 Changzhou Siyao Pharmaceutical

9 Development Trend of Analysis of Fluoxetine Market

• 9.1 Global Fluoxetine Market Trend Analysis
  • 9.1.1 Global Fluoxetine Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Fluoxetine Regional Market Trend
  • 9.2.1 North America Fluoxetine Forecast 2019-2025
  • 9.2.2 Europe Fluoxetine Forecast 2019-2025
  • 9.2.3 China Fluoxetine Forecast 2019-2025
  • 9.2.4 Japan Fluoxetine Forecast 2019-2025
  • 9.2.5 Southeast Asia Fluoxetine Forecast 2019-2025
  • 9.2.6 India Fluoxetine Forecast 2019-2025
• 9.3 Fluoxetine Market Trend (Product Type)
• 9.4 Fluoxetine Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Fluoxetine Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List